Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-23T10:41:37.311Z Has data issue: false hasContentIssue false
  • English
  • Français

An Association of Intrusive, Repetitive Phrases with Lamotrigine Treatment in Bipolar II Disorder

Published online by Cambridge University Press:  07 November 2014

David E. Kemp ,
William S. Gilmer ,
Jenelle Fleck  and
Pedro L. Dago
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction:

Bipolar disorder is frequently associated with obsessional symptoms. However, no reports have identified a pattern of obsessionality that is associated with a specific mood stabilizer treatment.

Methods:

A chart review was conducted on five patients with bipolar II disorder who spontaneously reported a form of obsessionality characterized by intrusive, recurrent phrases after taking lamotrigine.

Results:

Development of the phrases occurred from 7–42 years after mood disorder onset and occurred only after initiation of lamotrigine treatment. The phrases improved with lamotrigine discontinuation or dose reduction and recurred with lamotrigine re-challenge or upon dose escalation.

Conclusion:

A possible mechanism for the development of the intrusive phrases involves the influence of lamotrigine on glutamatergic regulation in a bipolar II disorder population vulnerable to the expression of obsessionality. Limitations of this report include its observational nature, small number of cases reported, and confound of concomitant medication use.

Type
Original Research
Information
CNS Spectrums , Volume 12 , Issue 2 , February 2007 , pp. 106 - 111
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Calabrese, JR, Bowden, CL, Sachs, G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry. 2003;64:1013–1024.CrossRefGoogle ScholarPubMed
2.Calabrese, JR, Bowden, CL, Sachs, GS, et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry. 1999;60:79–88.CrossRefGoogle ScholarPubMed
3.Fornaro, P, Giberti, F, Albano, C, et al. Lamotrigine in the treatment of major depression. Preliminary results from an open study on outpatients. Int J Psychiatry Behavior Sci. 1998;8:114–118.Google Scholar
4.Leonard, HL, Lenane, MC, Swedo, SE, Rettew, DC, Gershon, ES, Rapoport, JL. Tics and Tourette's disorder: a 2- to 7-year follow-up of 54 obsessive-compulsive children. Am J Psychiatry. 1992;149:1244–1251.Google ScholarPubMed
5.Sotero de Menezes, MA, Rho, JM, Murphy, P, Cheyette, S. Lamotrigine-induced tic disorder: report of five pediatric cases. Epilepsia. 2000;41:862–867.CrossRefGoogle ScholarPubMed
6.Lombroso, CT. Lamotrigine-induced tourettism. Neurology. 1999;52:1191–1194.CrossRefGoogle ScholarPubMed
7.Seemuller, FDS, Grunze, H, Muller, N. Tourette's symptoms provoked by lamotrigine in a bipolar patient. Am J Psychiatry. 2006;163:159.CrossRefGoogle Scholar
8.Perugi, G, Akiskal, HS, Pfanner, C, et al. The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorder. J Affect Disord 1997;46:15–23.CrossRefGoogle ScholarPubMed
9.Kruger, S, Braunig, P, Cooke, RG. Comorbidity of obsessive-compulsive disorder in recovered inpatients with bipolar disorder. Bipolar Disord. 2000;2:71–74.CrossRefGoogle ScholarPubMed
10.McElroy, SL, Strakowski, SM, Keck, PE Jr, Tugrul, KL, West, SA, Lonczak, HS. Differences and similarities in mixed and pure mania. Compr Psychiatry. 1995;36:187–194.CrossRefGoogle ScholarPubMed
11.Strakowski, SM, Sax, KW, McElroy, SL, Keck, PE Jr, Hawkins, JM, West, SA. Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after a first psychiatric hospitalization. J Clin Psychiatry. 1998;59:465–471.CrossRefGoogle ScholarPubMed
12.Khullar, A, Chue, P, Tibbo, P. Quetiapine and obsessive-compulsive symptoms (OCS): case report and review of atypical antipsychotic-induced OCS. J Psychiatry Neurosci. 2001;26:55–59.Google ScholarPubMed
13.Tranulis, C, Potvin, S, Gourgue, M, Leblanc, G, Mancini-Marie, A, Stip, E. The paradox of quetiapine in obsessive-compulsive disorder. CNS Spectr. 2005;10:356–361.CrossRefGoogle ScholarPubMed
14.Mottard, JP, de la Sablonniere, JF. Olanzapine-induced obsessive-compulsive disorder. Am J Psychiatry. 1999;156:799–800.CrossRefGoogle ScholarPubMed
15.Ramasubbu, R, Ravindran, A, Lapierre, Y. Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs. Pharmacopsychiatry. 2000;33:236–238.CrossRefGoogle ScholarPubMed
16.Patil, VJ. Development of transient obsessive-compulsive symptoms during treatment with clozapine. Am J Psychiatry. 1992;149:272.Google ScholarPubMed
17.Hill, D, Mitchell, W. Epileptic anamnesis. Folia Psychiatr Neurol Neurochir Neerl. 1953;56:718–725.Google ScholarPubMed
18.Mendez, MF, Cherrier, MM, Perryman, KM. Epileptic forced thinking from left frontal lesions. Neurology. 1996;47:79–83.CrossRefGoogle ScholarPubMed
19.van der Zwaard, R, Polak, MA. Pseudohallucinations: a pseudoconcept? A review of the validity of the concept, related to associate symptomatology. Compr Psychiatry. 2001;42:42–50.CrossRefGoogle ScholarPubMed
20.Hantouche, EG, Angst, J, Demonfaucon, C, et al. Cyclothymic OCD: a distinct form? J Affect Disord. 2003;75:1–10.CrossRefGoogle ScholarPubMed
21.Chen, YW, Dilsaver, SC. Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders. Psychiatry Res. 1995;59:57–64.CrossRefGoogle ScholarPubMed
22.Swartz, CM, Shen, WW. Is episodic obsessive compulsive disorder bipolar? A report of four cases. J Affect Disord. 1999;56:61–66.CrossRefGoogle ScholarPubMed
23.Saxena, S, Rauch, SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am. 2000;23:563–586.CrossRefGoogle ScholarPubMed
24.Insel, TR, Akiskal, HS. Obsessive-compulsive disorder with psychotic features: a phenomenologic analysis. Am J Psychiatry. 1986;143:1527–1533.Google ScholarPubMed
25.Keuneman, RJ, Pokos, V, Weerasundera, R, et al. Antipsychotic treatment in obsessive-compulsive disorder: a literature review. Aust N Z J Psychiatry. 2005;39:336–343.Google ScholarPubMed
26.Walsh, KH, McDougle, CJ. Pharmacological augmentation strategies for treatment-resistant obsessive-compulsive disorder. Expert Opin Pharmacother. 2004;5:2059–2067.CrossRefGoogle ScholarPubMed
27.Bolton, J, Moore, GJ, MacMillan, S, et al. Case study: caudate glutamatergic changes with paroxetine persist after medication discontinuation in pediatric OCD. J Am Acad Child Adolesc Psychiatry. 2001;40:903–906.CrossRefGoogle ScholarPubMed
28.Coric, V, Taskiran, S, Pittenger, C, et al. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biol Psychiatry. 2005;58:424–428.CrossRefGoogle ScholarPubMed
29.Moore, GJ, MacMaster, FP, Stewart, C, et al. Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 1998;37:663–667.CrossRefGoogle ScholarPubMed
30.Rosenberg, DR, Mirza, Y, Russell, A, et al. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry. 2004;43:1146–1153.CrossRefGoogle ScholarPubMed
31.Rosenberg, DR, MacMaster, FP, Keshavan, MS, et al. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry. 2000;39:1096–1103.CrossRefGoogle ScholarPubMed
32.Kuo, CC, Lu, L. Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurones. Br J Pharmacol. 1997;121:1231–1238.CrossRefGoogle ScholarPubMed
33.Wang, SJ, Huang, CC, Hsu, KS, et al. Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones. Neuroreport. 1996;7:3037–3040.CrossRefGoogle ScholarPubMed
34.Wang, SJ, Sihra, TS, Gean, PW. Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals (synaptosomes) by suppression of voltage-activated calcium channel activity. Neuroreport. 2001;12:2255–2258.CrossRefGoogle ScholarPubMed
35.Keshavan, MS. Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J Psychiatr Res. 1999;33:513–521.CrossRefGoogle ScholarPubMed
36.Michael, N, Erfurth, A, Ohrmann, P, et al. Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex. Psychopharmacology (Berl). 2003;168:344–346.CrossRefGoogle ScholarPubMed
37.Castillo, M, Kwock, L, Courvoisie, H, et al. Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations. AJNR Am J Neuroradiol. 2000;21:832–838.Google ScholarPubMed